Coordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cells

被引:89
作者
Hardy, TA [1 ]
May, JM [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
关键词
nitric oxide; nitric oxide synthase; compartmentation; L-arginine transport; bovine aortic endothelial cells; free radicals;
D O I
10.1016/S0891-5849(01)00781-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite intracellular L-arginine concentrations that should saturate endothelial nitric oxide synthase (cNOS), nitric oxide production depends on extracellular L-arginine. We addressed this 'arginine paradox' in bovine aortic endothelial cells by simultaneously comparing the substrate dependence of L-arginine uptake and intracellular cNOS activity, the latter measured as L- [H-3]arginine conversion to L- [H-3]citrulline. Whereas the K-m of eNOS for L-arginine was 2 muM in cell extracts, the L-arginine concentration of half-maximal eNOS stimulation was increased to 29 muM in intact cells. This increase likely reflects limitation by L-arginine uptake, which had a K-m of 108 muM. The effects of inhibitors of endothelial nitric oxide synthesis also suggested that extracellular L-arginine availability limits intracellular eNOS activity. Treatment of intact cells with the calcium ionophore A23187 reduced the L-arginine concentration of half-maximal eNOS activity, which is consistent with a measured increase in L-arginine uptake. Increases in eNOS activity induced by several agents were closely correlated with enhanced L-arginine uptake into cells (r=0.89). The 'arginine paradox' may be explained in part by regulated L-arginine uptake into a compartment, probably represented by caveolae, that contains eNOS and that is distinct from the bulk cytosolic L-arginine. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:122 / 131
页数:10
相关论文
共 44 条
[1]   L-ARGININE AVAILABILITY DETERMINES THE DURATION OF ACETYLCHOLINE-INDUCED SYSTEMIC VASODILATATION INVIVO [J].
AISAKA, K ;
GROSS, SS ;
GRIFFITH, OW ;
LEVI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 163 (02) :710-717
[2]   INTERACTIONS BETWEEN L-ARGININE AND L-GLUTAMINE CHANGE ENDOTHELIAL NO PRODUCTION - AN EFFECT INDEPENDENT OF NO SYNTHASE SUBSTRATE AVAILABILITY [J].
ARNAL, JF ;
MUNZEL, T ;
VENEMA, RC ;
JAMES, NL ;
BAI, CL ;
MITCH, WE ;
HARRISON, DG .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2565-2572
[3]   SUBSTRATE-DEPENDENT REGULATION OF INTRACELLULAR AMINO-ACID-CONCENTRATIONS IN CULTURED BOVINE AORTIC ENDOTHELIAL-CELLS [J].
BAYDOUN, AR ;
EMERY, PW ;
PEARSON, JD ;
MANN, GE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 173 (03) :940-948
[4]   Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease [J].
Böger, RH ;
Bode-Böger, SM ;
Thiele, W ;
Creutzig, A ;
Alexander, K ;
Fröhlich, JC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) :1336-1344
[5]   BRADYKININ AND ATP STIMULATE L-ARGININE UPTAKE AND NITRIC-OXIDE RELEASE IN VASCULAR ENDOTHELIAL-CELLS [J].
BOGLE, RG ;
COADE, SB ;
MONCADA, S ;
PEARSON, JD ;
MANN, GE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (02) :926-932
[6]   L-ARGININE TRANSPORT IS INCREASED IN MACROPHAGES GENERATING NITRIC-OXIDE [J].
BOGLE, RG ;
BAYDOUN, AR ;
PEARSON, JD ;
MONCADA, S ;
MANN, GE .
BIOCHEMICAL JOURNAL, 1992, 284 :15-18
[7]   NITRIC-OXIDE MEDIATES GLUTAMATE-LINKED ENHANCEMENT OF CGMP LEVELS IN THE CEREBELLUM [J].
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :9030-9033
[8]   ISOLATION OF NITRIC-OXIDE SYNTHETASE, A CALMODULIN-REQUIRING ENZYME [J].
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :682-685
[9]   Studies of L-arginine transport in bovine aortic endothelial cells [J].
Casey, TE ;
Harrison, AC ;
Zimmerman, JK ;
Hilderman, RH .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 379 (02) :283-291
[10]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099